Endogenous cannabinoid system as a modulator of food intake

[1]  A. Hiltunen,et al.  Enantiomeric cannabinoids: stereospecificity of psychotropic activity , 1988, Experientia.

[2]  M. Abood.  Molecular biology of cannabinoid receptors. , 2005, Handbook of experimental pharmacology.

[3]  R. Wise,et al.  Facilitory effect of Δ9-tetrahydrocannabinol on hypothalamically induced feeding , 2005, Psychopharmacology.

[4]  G. Kunos,et al.  Novel Physiologic Functions of Endocannabinoids as Revealed Through the Use of Mutant Mice , 2001, Neurochemical Research.

[5]  P. Bender,et al.  Cannabinols and feeding in sheep , 1979, Psychopharmacology.

[6]  J. Mendelson,et al.  Effects of marihuana use on body weight and caloric intake in humans , 1976, Psychopharmacology.

[7]  E. A. Carlim,et al.  Effects of Cannabis sativa (marihuana) on maze performance of the rat , 1965, Psychopharmacologia.

[8]  R. Sofia,et al.  Acute and chronic effects of δ9-tetrahydrocannabinol on food intake by rats , 2004, Psychopharmacologia.

[9]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[10]  J. Ramos,et al.  UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. , 2002, European journal of pharmacology.

[11]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[12]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[14]  V. Marzo,et al.  Targeting the endocannabinoid system in cancer therapy: A call for further research , 2002, Nature Medicine.

[15]  T. Kirkham,et al.  Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine , 2002, Pharmacology Biochemistry and Behavior.

[16]  G. Marsicano,et al.  Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain , 2002, Neuroscience.

[17]  T. Kirkham,et al.  Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. , 2002, Pharmacology, biochemistry, and behavior.

[18]  S. Bloom,et al.  Hypothalamic peptides as drug targets for obesity. , 2001, Current opinion in pharmacology.

[19]  S. Gaetani,et al.  An anorexic lipid mediator regulated by feeding , 2001, Nature.

[20]  N. Jamshidi,et al.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.

[21]  M. Kathmann,et al.  Modulation of transmitter release via presynaptic cannabinoid receptors. , 2001, Trends in pharmacological sciences.

[22]  S. Ben-Shabat,et al.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury , 2001, Nature.

[23]  G. Kennett,et al.  Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors , 2001, Neuropharmacology.

[24]  G. Koob,et al.  Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration , 2001, The Journal of Neuroscience.

[25]  S. Batkai,et al.  Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. , 2001, European journal of pharmacology.

[26]  C. Ledent,et al.  The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. , 2001, Biochemical and biophysical research communications.

[27]  T. Kirkham,et al.  Endogenous cannabinoids and appetite , 2001, Nutrition Research Reviews.

[28]  T. Arzberger,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence f , 2022 .

[29]  R. Mechoulam,et al.  Physiology: A hunger for cannabinoids , 2001, Nature.

[30]  R. Palmiter,et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.

[31]  S. Heishman,et al.  Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. , 2001, Archives of general psychiatry.

[32]  C. Felder,et al.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention. , 2001, Pharmacology & therapeutics.

[33]  K. Connolly,et al.  Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids , 2001, Neuroscience Letters.

[34]  Z. Vogel,et al.  2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Koch.  Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets , 2001, Pharmacology Biochemistry and Behavior.

[36]  L. Porrino,et al.  Effects of SR141716A on ethanol and sucrose self-administration. , 2001, Alcoholism, clinical and experimental research.

[37]  J. Koch.  Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. , 2001, Pharmacology, biochemistry, and behavior.

[38]  H. Zoghbi,et al.  Bidirectional control of airway responsiveness by endogenous cannabinoids , 2000, Nature.

[39]  L. Petrocellis,et al.  Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. , 2000, Chemistry and physics of lipids.

[40]  T. Bisogno,et al.  Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity , 2000, FEBS letters.

[41]  L. Porrino,et al.  Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding , 2000, Pharmacology Biochemistry and Behavior.

[42]  K. Green,et al.  Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[43]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[44]  T. Bisogno,et al.  Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol‐Tolerant Rats , 2000, Journal of neurochemistry.

[45]  E. Berry,et al.  Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. , 2000, European journal of pharmacology.

[46]  M. Cortés,et al.  Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation , 2000, Nature Medicine.

[47]  T. Kirkham,et al.  Synergistic efects of opioid and cannabinoid antagonists on food intake , 2000, Psychopharmacology.

[48]  G. Marsicano,et al.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.

[49]  T. Hökfelt,et al.  Cholecystokinin/opioid interactions , 1999, Brain Research.

[50]  F. Weiss,et al.  The dopamine hypothesis of reward: past and current status , 1999, Trends in Neurosciences.

[51]  R. Gorter.  Cancer Cachexia and Cannabinoids , 1999, Complementary Medicine Research.

[52]  J. Manzanares,et al.  Identification of Endocannabinoids and Cannabinoid CB1 Receptor mRNA in the Pituitary Gland , 1999, Neuroendocrinology.

[53]  L. Petrocellis,et al.  Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response , 1999, Neuroscience.

[54]  A. Ameri.  The effects of cannabinoids on the brain , 1999, Progress in Neurobiology.

[55]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  I. McGregor,et al.  Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. , 1999, European journal of pharmacology.

[57]  T. Kirkham,et al.  Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors , 1999, Psychopharmacology.

[58]  T. Bisogno,et al.  Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. , 1999, Biochemical and biophysical research communications.

[59]  I. McGregor,et al.  The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716 , 1999, Psychopharmacology.

[60]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[61]  R. Gralla.  Cannabinoids and the Control of Chemotherapy-Induced Nausea and Vomiting , 1999 .

[62]  M. Thiébot,et al.  Behavioral Effects of Cannabinoid Agents in Animals. , 1999, Critical reviews in neurobiology.

[63]  G. Nahas.  Marihuana and Medicine , 1999, Humana Press.

[64]  E. Gardner,et al.  Cannabinoid Transmission and Reward-Related Events , 1998, Neurobiology of Disease.

[65]  L. Murphy,et al.  Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion , 1998, Neurobiology of Disease.

[66]  C. Breivogel,et al.  The Functional Neuroanatomy of Brain Cannabinoid Receptors , 1998, Neurobiology of Disease.

[67]  L. Petrocellis,et al.  Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action , 1998, Trends in Neurosciences.

[68]  P. Rogers,et al.  Hyperphagia in pre-fed rats following oral δ9-THC , 1998, Physiology & Behavior.

[69]  G. Gessa,et al.  Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. , 1998, Life sciences.

[70]  J. Simiand,et al.  SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. , 1998, Behavioural pharmacology.

[71]  P. Casellas,et al.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[72]  A. Makriyannis,et al.  AM630 is an inverse agonist at the human cannabinoid CB1 receptor. , 1998, Life sciences.

[73]  P. Rogers,et al.  Hyperphagia in pre-fed rats following oral delta9-THC. , 1998, Physiology & behavior.

[74]  L. Volicer,et al.  Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease , 1997, International journal of geriatric psychiatry.

[75]  D. Piomelli,et al.  Functional role of high-affinity anandamide transport, as revealed by selective inhibition. , 1997, Science.

[76]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[77]  W. Powderly,et al.  Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. , 1997, Journal of pain and symptom management.

[78]  P. Soubrié,et al.  Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors , 1997, Psychopharmacology.

[79]  S. Burstein.  Marijuana as a medicine , 1997, Nature.

[80]  R. Faull,et al.  Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain , 1997, Neuroscience.

[81]  F. Rodríguez de Fonseca,et al.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the rat , 1997, Neuroreport.

[82]  K. Berridge.  Food reward: Brain substrates of wanting and liking , 1996, Neuroscience & Biobehavioral Reviews.

[83]  M. Palkovits,et al.  Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat , 1996, FEBS letters.

[84]  R. Palmiter,et al.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.

[85]  A. Yamashita,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[86]  K. Mackie,et al.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.

[87]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[88]  K. Shepard,et al.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. , 1995, Journal of pain and symptom management.

[89]  Jacqueline N. Crawley,et al.  Biological actions of cholecystokinin , 1994, Peptides.

[90]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[91]  L. Shaw,et al.  Cannabinoids and appetite stimulation , 1994, Pharmacology Biochemistry and Behavior.

[92]  P. Soubrié,et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.

[93]  S. Almog,et al.  Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. , 1993, Journal of medicinal chemistry.

[94]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[95]  C. Geiger,et al.  Effect of Dronabinol on Nutritional Status in HIV Infection , 1993, The Annals of pharmacotherapy.

[96]  S. Cooper,et al.  Opioid Mechanisms in the Control of Food Consumption and Taste Preferences , 1993 .

[97]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[98]  P. Volberding,et al.  Dronabinol effects on weight in patients with HIV infection. , 1992, AIDS.

[99]  K. Shepard,et al.  Recent clinical experience with dronabinol , 1991, Pharmacology Biochemistry and Behavior.

[100]  R. Wise,et al.  Facilitory effect of delta 9-tetrahydrocannabinol on hypothalamically induced feeding. , 1991, Psychopharmacology.

[101]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[102]  A. Howlett,et al.  Classical and nonclassical cannabinoids: mechanism of action--brain binding. , 1990, NIDA research monograph.

[103]  R. Foltin,et al.  Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory , 1988, Appetite.

[104]  J. Brady,et al.  Behavioral analysis of marijuana effects on food intake in humans , 1986, Pharmacology Biochemistry and Behavior.

[105]  B. G. Hoebel.  Brain neurotransmitters in food and drug reward. , 1985, The American journal of clinical nutrition.

[106]  C. Baile,et al.  Oral and hypothalamic injections of barbiturates, benzodiazepines and cannabinoids and food intake in rats , 1979, Pharmacology Biochemistry and Behavior.

[107]  C. Baile,et al.  Feeding and depression of abomasal secretion in sheep elicited by elfazepam and 9- aza-cannabinol , 1979, Pharmacology Biochemistry and Behavior.

[108]  J. E. Brown,et al.  Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol. , 1977, Behavioral biology.

[109]  E. Gehan,et al.  Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria , 1977, Cancer.

[110]  E. Abel.  Cannabis: effects on hunger and thirst. , 1975, Behavioral biology.

[111]  S. Sallan,et al.  Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. , 1975, The New England journal of medicine.

[112]  R. Carchman,et al.  Antineoplastic activity of cannabinoids. , 1975, Journal of the National Cancer Institute.

[113]  M. Gagnon,et al.  [Effects of marijuana and D-amphetamine on the appetite, food consumption and various cardio-respiratory variables in man]. , 1975, L'union medicale du Canada.

[114]  G. R. Thompson,et al.  Oral and intravenous toxicity of Δ9-tetrahydrocannabinol in rhesus monkeys☆☆☆ , 1974 .

[115]  R. Sofia,et al.  Acute and chronic effects of delta9-tetrahydrocannabinol on food intake by rats. , 1974, Psychopharmacologia.

[116]  H. Coper,et al.  Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat. , 1974, Psychopharmacologia.

[117]  G. R. Thompson,et al.  Oral and intravenous toxicity of delta9-tetrahydrocannabinol in rhesus monkeys. , 1974, Toxicology and applied pharmacology.

[118]  P. Sjödén,et al.  Influence of tetrahydrocannabinols (delta8-THC and delta9-THC) on body weight, food, and water intake in rats. , 1973, Pharmacology, biochemistry, and behavior.

[119]  J. Kennedy,et al.  Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents. , 1972, Archives internationales de pharmacodynamie et de therapie.

[120]  F. Manning,et al.  Inhibition of Normal Growth by Chronic Administration of Δ-9-Tetrahydrocannabinol , 1971, Science.

[121]  E. Abel.  Effects of Marihuana on the Solution of Anagrams, Memory and Appetite , 1971, Nature.

[122]  L. Hollister.  Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine , 1971, Clinical pharmacology and therapeutics.

[123]  F. Manning,et al.  Inhibition of normal growth by chronic administration of delta-9-tetrahydrocannabinol. , 1971, Science.

[124]  C. Tart,et al.  Marijuana Intoxication : Common Experiences , 1970, Nature.

[125]  L. Haines,et al.  Marijuana use patterns. , 1970, The British journal of addiction to alcohol and other drugs.

[126]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[127]  R. Chopra,et al.  PRESENT POSITION OF HEMP DRUG ADDICTION IN INDIA , 1940 .